Clinical Research Support
Clinical Trials Education Office (CTEO)
NCI Investigator Registration
National Cancer Institute (NCI) investigator numbers are required for all Dana-Farber/Harvard Cancer Center (DF/HCC) attending physicians who will obtain consent from subjects for research related therapy or who will write orders for research related therapy. The NCI investigator registration process is centralized in the Quality Assurance Office for Clinical Trials (QACT) at Dana-Farber Cancer Institute (DFCI) for all DF/HCC attending physicians.
To check the registration status and NCI Investigator Number for a DF/HCC attending physician, please click here.
A completed (with original signature) Statement of Investigator Form (Form FDA 1572), Supplemental Investigator Form (IDF) and Financial Disclosure Form, along with a Curriculum Vitae (CV) must be sent to the QACT.
The renewal process occurs between the months of June-August each year. All DF/HCC attending physicians must renew their registrations at this time regardless of when they last registered.
The renewal process consists of submitting a completed (with original signature) Statement of Investigator Form (Form FDA 1572), Supplemental Investigator Form (IDF) and Financial Disclosure Form, along with a Curriculum Vitae (CV) to the QACT. These forms are distributed to attending physicians in bright red envelopes in early June. Each red envelope contains the necessary forms as well as instructions on how to complete the forms and the deadline for form submission.
If you have any questions about DF/HCC's NCI Investigator Registration or renewal process, please contact QACT@partners.org.
Instructions and Forms